scispace - formally typeset
L

Long Sun

Researcher at Fujian Medical University

Publications -  33
Citations -  899

Long Sun is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Medicine & PET-CT. The author has an hindex of 11, co-authored 20 publications receiving 408 citations.

Papers
More filters
Journal ArticleDOI

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

TL;DR: [68Ga]Ga-DOTA-FAPI-04 PET/CT showed a superior diagnostic efficacy than [18F] FDGPET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer, especially in identifying liver metastases, peritoneal carcinomatosis, and brain tumours.
Journal ArticleDOI

Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings

TL;DR: In patients undergoing oncological evaluation with inconclusive [ 18 F]FDG PET/CT findings, [ 68 Ga]Ga-DOTA-FAPI-04 may have a complementary role in discriminating mass lesions on conventional imaging, locating the primary site of unknown malignancy, modifying tumour staging, and detecting suspected disease recurrence.
Journal ArticleDOI

Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.

TL;DR: W whole body (18)F-FDG PET/CT was highly effective in discriminating true recurrence in post-operative patients with gastric cancer and had important impacts on clinical decisions in a considerable portion of patients.
Journal ArticleDOI

Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging.

TL;DR: A variety of imaging procedures available for detecting ulcerative colitis and Crohn's disease, polyps and CRC in their early stage are reviewed and details on various screening options are presented.
Journal ArticleDOI

Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review

TL;DR: The literature for the state-of-the-art FAPI-PET imaging for cancer diagnosis compared with fluorodeoxyglucose (FDG)-PET is summarized and the use of FAP-PET for therapeutic regimen improvement and fibroblast activation protein (FAP)-targeted molecule modification strategies is summarized.